Axsome Therapeutics Inc (AXSM)
75.76
-0.18
(-0.24%)
USD |
NASDAQ |
May 07, 14:57
Axsome Therapeutics Total Assets (Quarterly): 588.24M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 588.24M |
| September 30, 2023 | 600.86M |
| June 30, 2023 | 611.64M |
| March 31, 2023 | 389.18M |
| December 31, 2022 | 331.48M |
| September 30, 2022 | 338.96M |
| June 30, 2022 | 180.56M |
| March 31, 2022 | 88.56M |
| December 31, 2021 | 87.79M |
| September 30, 2021 | 116.60M |
| June 30, 2021 | 143.26M |
| March 31, 2021 | 166.90M |
| December 31, 2020 | 186.13M |
| September 30, 2020 | 203.63M |
| June 30, 2020 | 190.99M |
| March 31, 2020 | 197.80M |
| December 31, 2019 | 220.55M |
| September 30, 2019 | 44.44M |
| Date | Value |
|---|---|
| June 30, 2019 | 54.78M |
| March 31, 2019 | 43.90M |
| December 31, 2018 | 15.38M |
| September 30, 2018 | 16.13M |
| June 30, 2018 | 21.73M |
| March 31, 2018 | 27.94M |
| December 31, 2017 | 35.56M |
| September 30, 2017 | 32.62M |
| June 30, 2017 | 39.04M |
| March 31, 2017 | 46.41M |
| December 31, 2016 | 38.21M |
| September 30, 2016 | 34.92M |
| June 30, 2016 | 40.01M |
| March 31, 2016 | 45.15M |
| December 31, 2015 | 49.08M |
| September 30, 2015 | 6.138M |
| June 30, 2015 | 6.875M |
| December 31, 2014 | 2.786M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.44M
Minimum
Sep 2019
611.64M
Maximum
Jun 2023
249.60M
Average
190.99M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Krystal Biotech Inc | 818.36M |
| Amgen Inc | 92.98B |
| Vertex Pharmaceuticals Inc | 22.73B |
| Alnylam Pharmaceuticals Inc | 3.824B |
| Catalyst Pharmaceuticals Inc | 470.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 397.26M |
| Shareholders Equity (Quarterly) | 190.98M |
| Debt to Equity Ratio | 0.9324 |
| Current Ratio | 3.632 |
| Net Debt Paydown Yield | -0.45% |